Stroke
- PMID: 18468545
- DOI: 10.1016/S0140-6736(08)60694-7
Stroke
Abstract
Stroke is the second most common cause of death and major cause of disability worldwide. Because of the ageing population, the burden will increase greatly during the next 20 years, especially in developing countries. Advances have occurred in the prevention and treatment of stroke during the past decade. For patients with acute stroke, management in a stroke care unit, intravenous tissue plasminogen activator within 3 h or aspirin within 48 h of stroke onset, and decompressive surgery for supratentorial malignant hemispheric cerebral infarction are interventions of proven benefit; several other interventions are being assessed. Proven secondary prevention strategies are warfarin for patients with atrial fibrillation, endarterectomy for symptomatic carotid stenosis, antiplatelet agents, and cholesterol reduction. The most important intervention is the management of patients in stroke care units because these provide a framework within which further study might be undertaken. These advances have exposed a worldwide shortage of stroke health-care workers, especially in developing countries.
Comment in
-
Secondary prevention of stroke.Lancet. 2008 Sep 20;372(9643):1035; author reply 1036. doi: 10.1016/S0140-6736(08)61437-3. Lancet. 2008. PMID: 18805325 No abstract available.
-
Secondary prevention of stroke.Lancet. 2008 Sep 20;372(9643):1036; author reply 1036. doi: 10.1016/S0140-6736(08)61438-5. Lancet. 2008. PMID: 18805327 No abstract available.
Similar articles
-
The intensive care management of acute ischemic stroke: an overview.Intensive Care Med. 2014 May;40(5):640-53. doi: 10.1007/s00134-014-3266-z. Intensive Care Med. 2014. PMID: 24658914 Review.
-
Differences in medical and surgical therapy for stroke prevention between leading experts in North America and Western Europe.Stroke. 1998 Feb;29(2):339-45. doi: 10.1161/01.str.29.2.339. Stroke. 1998. PMID: 9472871
-
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke.Lancet. 2011 May 14;377(9778):1681-92. doi: 10.1016/S0140-6736(11)60516-3. Lancet. 2011. PMID: 21571151 Review.
-
Warfarin for atrial fibrillation: the end of an era?Lancet Neurol. 2004 May;3(5):305-8. doi: 10.1016/S1474-4422(04)00738-0. Lancet Neurol. 2004. PMID: 15099545 Review.
-
[Stroke prevention].Ther Umsch. 2003 Sep;60(9):521-6. doi: 10.1024/0040-5930.60.9.521. Ther Umsch. 2003. PMID: 14579620 Review. German.
Cited by
-
MicroRNAs: protective regulators for neuron growth and development.Neural Regen Res. 2023 Apr;18(4):734-745. doi: 10.4103/1673-5374.353481. Neural Regen Res. 2023. PMID: 36204829 Free PMC article. Review.
-
Acute Statin Treatment Improves Recovery after Experimental Intracerebral Hemorrhage.World J Neurosci. 2013 May;3(2):69-75. doi: 10.4236/wjns.2013.32010. World J Neurosci. 2013. PMID: 23837132 Free PMC article.
-
Humanin and age-related diseases: a new link?Front Endocrinol (Lausanne). 2014 Dec 4;5:210. doi: 10.3389/fendo.2014.00210. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25538685 Free PMC article. Review.
-
Effect of human mesenchymal stem cell transplantation on cerebral ischemic volume-controlled photothrombotic mouse model.Biotechnol J. 2016 Nov;11(11):1397-1404. doi: 10.1002/biot.201600057. Epub 2016 Oct 11. Biotechnol J. 2016. PMID: 27440447 Free PMC article.
-
Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.BMC Neurosci. 2016 May 3;17(1):19. doi: 10.1186/s12868-016-0253-z. BMC Neurosci. 2016. PMID: 27142074 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous